A drug from AstraZeneca and Daiichi Sankyo won authorization for a form of breast cancer, the first U.S. approval for the ...

Breast cancer has long been a significant health concern for women, but recent trends show an unsettling increase in ...

Having counseled thousands of patients through their breast cancer diagnosis, I was fully aware of how nondiscriminatory this ...

It’s a sobering statistic: 1 in 8 women in the United States will be diagnosed with breast cancer during her lifetime.1 ...

The U.S. Food and Drug Administration has approved AstraZeneca and partner Daiichi Sankyo's precision drug to treat a type of ...

The increase in breast cancer rates among younger patients is occurring as the incidence of other early-onset cancers — ...

Questions about sex and intimacy often go unanswered for people with cancer. It's a glaring problem, especially for the ...

Two new studies have identified a possible way to block the progression of several forms of blood cancer using a drug already in clinical trials against breast cancer.

Several major drugmakers have restricted commercially insured patients from their patient assistance programs, leaving ...

Patient outcomes appeared to be more heavily driven by breast cancer stage than delays in diagnosis, researchers found.

During a Case-Based Roundtable event, Laura Huppert, MD, reviewed antibody-drug conjugates for a patient with metastatic ...

The US Food and Drug Administration (FDA) has approved datopotamab deruxtecan for the treatment of certain patients with ...